[HTML][HTML] Neurokinin 1/3 receptor antagonists for menopausal women: A current systematic review and insights into the investigational non-hormonal therapy

F Hassan, A Saleem, SS Samuel, Z Sarfraz, A Sarfraz… - Medicine, 2023 - journals.lww.com
Background: Over 75% of menopausal women experience vasomotor symptoms (VMS),
such as night sweats and hot flashes. Despite the prevalence of these symptoms, there is …

Genitourinary syndrome of menopause

JM Marino - Journal of Midwifery & Women's Health, 2021 - Wiley Online Library
Genitourinary syndrome of menopause (GSM) occurs in approximately 50% of menopausal
women but is both underrecognized and undertreated despite numerous treatment options …

Recurrent urinary tract infection in adult patients, risk factors, and efficacy of low dose prophylactic antibiotics therapy

H Alghoraibi, A Asidan, R Aljawaied… - Journal of Epidemiology …, 2023 - Springer
Background Recurrent urinary tract infection (UTI) occurs in sizable percentages of patients
after a single episode and is a frequent cause of primary healthcare visits and hospital …

The role of hormone therapy in urogenital health after menopause

RE Nappi, L Cucinella, E Martini, C Cassani - Best Practice & Research …, 2021 - Elsevier
Menopause represents an endocrine challenge to urogenital health, as oestrogens
deprivation and androgens decline significantly contributes to age-related involution of …

Sexual function in postmenopausal women with symptomatic pelvic organ prolapse treated either with locally applied estrogen or placebo: results of a double-masked …

ML Marschalek, K Bodner, O Kimberger… - The journal of sexual …, 2022 - academic.oup.com
Background Local estrogen therapy (LET) has beneficial effects on genitourinary atrophy;
however it is currently unclear if LET improves sexual function in postmenopausal women …

Recurrent UTI in Women–Risk Factors and Management

JE Lazarus, K Gupta - Infectious Disease Clinics, 2024 - id.theclinics.com
Urinary tract infections (UTIs) are common in women; more than 50% of women will be
diagnosed with a UTI in her lifetime. 1 Recurrent urinary tract infection (rUTI) is a diagnosis …

Strong evidence supports the use of estradiol therapy for the treatment of vaginal inflammation: a two-way Mendelian randomization study

X Xu, Y Liu, W Feng, J Shen - European Journal of Medical Research, 2024 - Springer
Objective Nowadays, there has been limited Mendelian randomization (MR) research
focusing on the causal relationship between estradiol and vaginitis. Therefore, this study …

Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper

AR Genazzani, H Divakar, SS Khadilkar… - South African General …, 2024 - journals.co.za
Menopause marks the end of menstrual cyclicity and, depending on individual vulnerability,
has several consequences related to gonadal steroid deprivation, especially if it is …

Surgical assessment of tissue quality during pelvic organ prolapse repair in postmenopausal women pre-treated either with locally applied estrogen or placebo …

ML Marschalek, K Bodner, O Kimberger… - Journal of Clinical …, 2021 - mdpi.com
The aim of this prospective randomized, double-masked, placebo-controlled, multicenter
study was to analyze the surgeon's individual assessment of tissue quality during pelvic floor …

Vaginal Estrogen as First-Line Therapy for Recurrent Urinary Tract Infections in Postmenopausal Women and Risk Factors for Needing Additional Therapy

E Chang, L Kent, I Prieto, E Eggers, JP Tanner… - …, 2021 - journals.lww.com
Objectives This retrospective cohort study aims to determine the proportion of
postmenopausal women with recurrent urinary tract infections (rUTIs) who improve with …